Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

The primary difference in the proposed legislation is that the rebates would go entirely to the plan sponsor, not split with the PBM. But the problem of rebates remains. Rebates distort decision ...

UnitedHealth Group reported mixed financial results for Q4, with a rise in medical care ratio and CEO's tribute to the late ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

At issue is the role pharmacy benefit mangers play in taking large discounts on drugs that advocates say are not passed along ...

Jan. 16 at 1:45 p.m. ETUnitedHealth Group's Optum Rx unit made a commitment to pass through 100% of rebates negotiated with ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

Says that while the company offers customers 100% pass-through options, “a small number have historically elected other models.” Witty says “We ...

UnitedHealth's CEO acknowledged discontent with the health care system, but quickly shifted the blame elsewhere.

FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...

The employer PBM sections in the original anti-down package ... would require PBMs to pass all rebates or discounts they negotiated for employer-sponsored health plans on to the employer plans.